Results 131 to 140 of about 1,791,803 (246)

Impact of respiratory motion on dose distribution in SIB‐SBRT for lung cancer

open access: yesJournal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose Respiratory motion is a major source of dose uncertainty in lung cancer radiotherapy. The dose distribution of simultaneous integrated boost‐stereotactic body radiotherapy (SIB‐SBRT) is inhomogeneous and is significantly impacted by respiratory motion for lung cancer. The effect of respiratory motion on SIB‐SBRT was investigated with a
Lingling Liu   +7 more
wiley   +1 more source

Adopting drone technology for blood delivery: a feasibility study to evaluate its efficiency and sustainability. [PDF]

open access: yesArch Public Health
Gauba P   +18 more
europepmc   +1 more source

Simulation‐free workflow for lattice radiation therapy using deep learning predicted synthetic computed tomography: A feasibility study

open access: yesJournal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose Lattice radiation therapy (LRT) is a form of spatially fractionated radiation therapy that allows increased total dose delivery aiming for improved treatment response without an increase in toxicities, commonly utilized for palliation of bulky tumors.
Libing Zhu   +9 more
wiley   +1 more source

Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges. [PDF]

open access: yesJ Nanobiotechnology
Sanadgol N   +6 more
europepmc   +1 more source

Validity and Reliability of Clinical and Patient‐Reported Outcomes in Multisystem Proteinopathy 1

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Valosin‐containing protein (VCP)‐associated multisystem proteinopathy 1 (MSP1) is caused by variants in the VCP gene. MSP1 results in various phenotypes including progressive myopathy, Paget's disease of bone, frontotemporal dementia, amyotrophic lateral sclerosis, and parkinsonism, among others.
Lindsay N. Alfano   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy